BioGaia AB ser. B (0GTN)

80.04
-435.46(-84.47%)
  • Volume:
    2,302
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    80.04 - 80.04

0GTN Overview

Prev. Close
515.5
Day's Range
80.04-80.04
Revenue
491.22M
Open
101.19
52 wk Range
69-113.16
EPS
2.44
Volume
2,302
Market Cap
8.12B
Dividend (Yield)
3.63
(0.95%)
Average Volume (3m)
3,504
P/E Ratio
211.33
Beta
0.595
1-Year Change
-
Shares Outstanding
100,982,310
Next Earnings Date
20 Oct 2022
What is your sentiment on BioGaia B?
or
Vote to see community's results!

BioGaia AB ser. B Analysis

BioGaia AB ser. B Company Profile

BioGaia AB ser. B Company Profile

Employees
189
Market
Sweden

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.

Read More

Analyst Price Target

Average138.67 (+72.47% Upside)
High168
Low118
Price80.4
No. of Analysts3
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyNeutralSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyBuy
SummaryStrong BuyStrong BuyStrong BuyNeutralNeutral